冠動脈バイパスグラフト装置市場：製品タイプ別、エンドユーザー別、地域別、2026～2032年

冠動脈バイパスグラフト装置の市場評価～2026～2032年

高齢化社会の進展が冠動脈バイパスグラフト（CABG）装置の成長を後押ししています。高齢化に伴い、冠動脈疾患（CAD）などの心臓疾患にかかりやすくなります。このような人口動態の変化はCADの罹患率の上昇につながり、CABG手技やこれらの疾患を効果的に管理・治療するために設計された機器の需要を押し上げます。このように、高齢者の増加は、市場規模の成長を急増させ、2024年には120億米ドルを突破し、2032年には202億7,000万米ドルの評価額に達します。

CADの危険因子と早期発見の重要性に対する認識の高まりは、より積極的なスクリーニングと診断につながっています。心臓病に対する社会の理解が深まるにつれ、危険因子を早期に特定し、予防措置を講じることが重視されるようになっています。このような意識の高まりは、CABG装置を含む診断や治療の選択肢に対する需要の増加につながります。高齢者の増加と積極的な健康対策が相まって、ヘルスケアシステムと患者が冠動脈疾患に対処・管理するための先進的なソリューションを求めるようになり、CABG機器市場の成長に拍車がかかっています。このように、CADに対する意識の高まりは、2026～2032年にかけてCAGR 7％で市場が成長することを可能にしています。

冠動脈バイパスグラフト装置市場定義/概要

冠動脈バイパスグラフト（CABG）手術は、冠動脈の狭窄や閉塞を特徴とする冠動脈疾患（CAD）に対処するために考案された重要な医療処置です。この外科的介入は、血液循環のための代替経路を作ることによって心筋への血流を改善することを目的としています。手技の間、外科医はグラフト（通常、足や胸など患者の体の他の部分から採取した健康な血管）を用いて冠動脈の閉塞部分をバイパスします。このバイパスにより、詰まった動脈の周囲で血流が方向転換され、心筋への酸素と栄養の供給が促進されます。

CABG手術は心臓に十分な血流を回復させるために行われ、胸痛（狭心症）や息切れなどのCADに伴う症状を緩和するために不可欠です。血液循環を改善することで、脳卒中のリスクも低下し、呼吸器合併症の可能性も低くなるため、患者さんにとって大きなメリットがあります。複数の動脈が閉塞している場合、外科医は最適な結果を得るために単一または複数のグラフトを使用することがあります。

低侵襲CABG手技は、切開の回数が少なく、手術時間も短く、回復時間の短縮や術後合併症のリスクの低下などの利点があるため、ますます好まれるようになっています。低侵襲手術にこれらのグラフトを使用することで、閉塞に効果的に対処し、心臓への健康な血流を回復させながらも、より低侵襲になり、手技の合理化に役立っています。

技術革新と患者転帰の改善が冠動脈バイパスグラフト装置市場の成長をどのように押し上げるか？

CABG手技の技術的進歩がこの市場拡大の最前線にあります。ロボット支援手術や内視鏡技術などの革新が心血管外科手術に変革をもたらし、患者の転帰を大幅に向上させています。これらの低侵襲的アプローチは外科的外傷を減らし、回復時間を短縮し、全体的な手術精度を向上させています。さらに市場を開拓しているのが先進的なロボット医療画像システムであり、外科医に高い精度と器用さを提供しています。これらのシステムは、術野の三次元ビューを提供し、従来型方法と比較して器具の動きをより柔軟にすることができます。さらに、術中血管造影や三次元画像などの画像技術の革新は、CABG手術中に冠動脈や心臓の構造を非常に詳細に可視化する能力に革命をもたらしました。

冠動脈疾患の有病率の上昇と高齢者の増加も市場促進要因として重要です。CABG処置は、脂肪の蓄積によって引き起こされる冠動脈の閉塞に対処するために不可欠です。冠動脈性心疾患の罹患率の増加は、主に座りがちなライフスタイル、食生活の乱れ、肥満率の上昇に起因しており、CABGのような効果的な治療オプションに対する需要が高まっています。この市場は、特に新興諸国におけるヘルスケア技術の進歩によってさらに支えられています。心血管治療用ポリマーベース修復器具の製造に対する多額の投資は、産業が技術革新と製品開発に注力していることを反映しています。各社は、心血管セグメントの進化するニーズに対応するため、新技術や新製品への投資を優先しています。

ロボット支援による低侵襲CABG手術は、切開回数が少なく、入院期間が短縮され、出血量が少なく、手術精度が高いなどの利点があるため、ますます好まれるようになっています。この動向は、先進的なCABG機器に対する需要を押し上げています。市場におけるヘルスケア施設の開拓も、CABG機器市場の成長に寄与しています。保健福祉省によるMillion Heartsイニシアチブのような医療インフラの強化や政府のイニシアチブは、心血管治療を改善し、心臓発作や脳卒中を減らすことを目的としています。このような公衆衛生への投資は、冠動脈疾患の治療オプションの進歩へのコミットメントを強調するものであり、市場の成長をさらに後押しするものです。

CABG手技に関連するコストは冠動脈バイパスグラフト装置市場の成長をどのように阻害するか？

CABG手術に関連する高コストは、冠動脈バイパスグラフト片市場の成長に課題を与えています。複雑で込み入った手術であるCABGはかなりの財政投資を必要とするため、特にヘルスケア保険や財源が限られている地域では患者のアクセスが制限される可能性があります。この高額な出費はヘルスケア予算に大きな負担となり、ヘルスケアシステム内の全体的な医療費負担や医療配分に影響を与える可能性があります。

さらに、インターベンショナルカーディオロジー技術との競合が激化していることも大きな障害となっています。血管形成術やステント留置術のような低侵襲手技は、CABGの代替手技としてますます採用されるようになっています。これらの手技は侵襲が少なく回復時間が短いという利点があるため、患者やヘルスケアプロバイダは従来型CABG手術よりもこれらの選択肢を好むようになります。このような治療の嗜好の変化は、CABG機器の需要を減少させ、市場の成長に影響を与える可能性があります。CABG手術に伴う固有のリスクも市場を抑制する一因となっています。この手術には出血、感染、脳卒中などの潜在的な合併症が伴い、患者の手術選択意欲を減退させ、ヘルスケアプロバイダにとっても課題となりえます。このようなリスクは、患者の予後を悪化させ、ヘルスケアコストを増加させ、一般的に手術を行うことに消極的になり、市場の需要にさらに影響を与える可能性があります。

さらに、熟練した心臓外科医が地域によって偏在しているため、CABG手技の利用が制限される可能性があります。有能な外科医が不足している地域では、患者は長い待ち行列や治療の遅れに直面する可能性があります。このようなアクセスの格差は、患者のケアに悪影響を及ぼし、十分なサービスを受けていない地域でのCABG機器の普及を遅らせる可能性があります。

目次

第1章 イントロダクション

• 市場の定義
• 市場セグメンテーション
• 調査手法

第2章 エグゼクティブサマリー

• 主要調査結果
• 市場概要
• 市場ハイライト

第3章 市場概要

• 市場規模と成長の可能性
• 市場動向
• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析

第4章 冠動脈バイパスグラフト装置市場：製品タイプ別

• オンポンプCABG装置
• オフポンプCABG装置
• 低侵襲CABG装置

第5章 冠動脈バイパスグラフト装置市場：エンドユーザー別

• 病院
• 心臓外科センター
• 外来手術センター

第6章 地域別分析

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• 英国
• ドイツ
• フランス
• イタリア
• アジア太平洋
• 中国
• 日本
• インド
• オーストラリア
• ラテンアメリカ
• ブラジル
• アルゼンチン
• チリ
• 中東・アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

第7章 市場力学

• 市場促進要因
• 市場抑制要因
• 市場機会
• COVID-19の市場への影響

第8章 競合情勢

• 主要企業
• 市場シェア分析

第9章 企業プロファイル

• Terumo Cardiovascular Systems Corporation
• Edwards Lifesciences Corporation
• Boston Scientific Corporation
• Medtronic
• Abbott
• Teleflex Incorporated
• AtriCure, Inc.

第10章 市場展望と機会

• 新興技術
• 今後の市場動向
• 投資機会

第11章 市場展望付録

• 略語リスト
• 供給源と参考文献

Coronary Artery Bypass Graft Devices Market Valuation - 2026-2032

The increasing aging population fuels the growth of coronary artery bypass graft devices. As people age, they become more susceptible to heart diseases, including coronary artery disease (CAD). This demographic shift contributes to a higher incidence of CAD, which in turn boosts the demand for CABG procedures and devices designed to manage and treat these conditions effectively. Thus, the growing geriatric population surge the growth of market size surpassing USD 12 Billion in 2024 to reach a valuation of USD 20.27 Billion by 2032.

Growing awareness of CAD risk factors and the importance of early detection have led to more proactive screening and diagnosis. As public understanding of heart disease improves, there is a greater emphasis on identifying risk factors early and taking preventive measures. This heightened awareness translates into increased demand for diagnostic and treatment options, including CABG devices. The combination of a rising elderly population and proactive health measures is fueli2028-2032ng the growth of the CABG devices market, as healthcare systems and patients seek advanced solutions to address and manage coronary artery disease. Thus, the increasing awareness of CAD enable the market to grow at a CAGR of 7% from 2026 to 2032.

Coronary Artery Bypass Graft Devices Market: Definition/ Overview

Coronary artery bypass graft (CABG) surgery is a crucial medical procedure designed to address coronary artery disease (CAD), a condition characterized by the narrowing or blockage of coronary arteries. This surgical intervention aims to improve blood flow to the heart muscle by creating alternative pathways for blood circulation. During the procedure, a surgeon utilizes grafts-typically healthy blood vessels taken from other parts of the patient's body, such as the leg or chest-to bypass the obstructed sections of the coronary arteries. This bypass redirects blood flow around the clogged arteries, enhancing the delivery of oxygen and nutrients to the heart muscle.

CABG surgery is performed to restore adequate blood flow to the heart, which is essential for alleviating symptoms associated with CAD, such as chest pain (angina) and shortness of breath. By improving blood circulation, the procedure also lowers the risk of stroke and reduces the likelihood of respiratory complications, offering significant benefits to patients. In cases where multiple arteries are blocked, surgeons may use single or multiple grafts to ensure optimal results.

Minimally invasive CABG techniques, which involve fewer incisions and a shorter operational time, are increasingly preferred due to their advantages, including reduced recovery time and lower risk of postoperative complications. The use of these grafts in minimally invasive surgeries helps streamline the procedure, making it less invasive while still effectively addressing the blockage and restoring healthy blood flow to the heart.

How the Innovations and Improving Patient Outcomes Surge the Growth of Coronary Artery Bypass Graft Devices Market?

Technological advancements in CABG procedures are at the forefront of this market expansion. Innovations such as robotic-assisted surgeries and endoscopic techniques have transformed cardiovascular surgery, significantly enhancing patient outcomes. These minimally invasive approaches reduce surgical trauma shorten recovery times and improve overall surgical precision. Further driving the market is the development of advanced robotic medical imaging systems, which provide surgeons with enhanced precision and dexterity. These systems offer a three-dimensional view of the surgical field and allow for greater flexibility in instrument movement compared to traditional methods. Additionally, innovations in imaging technologies, such as intraoperative angiography and three-dimensional imaging, have revolutionized the ability to visualize coronary arteries and cardiac structures in exceptional detail during CABG procedures.

The rise in coronary heart disease prevalence and the growing geriatric population are also crucial market drivers. CABG procedures are essential for addressing coronary artery blockages caused by fatty build-ups. With the increasing incidence of coronary heart disease, largely attributed to sedentary lifestyles, poor dietary habits, and rising obesity rates, there is a higher demand for effective treatment options like CABG. The market is further supported by advancements in healthcare technology, particularly in developing countries. Significant investments in the manufacture of polymer-based restorative devices for cardiovascular treatment reflect the industry's focus on innovation and product development. Companies are prioritizing investment in new technologies and products to meet the evolving needs of the cardiovascular sector.

Minimally invasive CABG surgeries, enabled by robotic assistance, have become increasingly preferred due to their benefits, including fewer incisions, reduced hospitalization periods, less blood loss, and higher surgical accuracy. This trend is pushing the demand for advanced CABG devices. The development of healthcare facilities in emerging markets is also contributing to the growth of the CABG devices market. Enhanced healthcare infrastructure and government initiatives, such as the Million Hearts initiative by the Department of Health & Human Services, aim to improve cardiovascular care and reduce heart attacks and strokes. Such public health investments underscore the commitment to advancing treatment options for coronary diseases, further boosting market growth.

How Does the Cost Associated with the CABG Procedure Impede the Growth of the Coronary Artery Bypass Graft Devices Market?

The high cost associated with CABG procedures challenges the growth of the coronary artery bypass graft devices market. As a complex and intricate surgery, CABG requires a considerable financial investment, which can limit patient access, especially in regions with limited healthcare coverage or financial resources. This high expense places a significant burden on healthcare budgets, potentially affecting the overall affordability and allocation of care within healthcare systems.

Additionally, the growing competition from interventional cardiology techniques presents a considerable restraint. Minimally invasive procedures such as angioplasty and stenting are increasingly being adopted as alternatives to CABG. These procedures offer the advantage of reduced invasiveness and shorter recovery times, which can lead patients and healthcare providers to prefer these options over traditional CABG surgery. This shift in treatment preferences can decrease the demand for CABG devices and impact market growth. The inherent risks associated with CABG surgery also play a role in restraining the market. The procedure carries potential complications, including bleeding, infection, and stroke, which can deter patients from opting for surgery and can also pose challenges for healthcare providers. These risks can lead to negative patient outcomes, increased healthcare costs, and a general reluctance to undertake the procedure, further impacting market demand.

Furthermore, the uneven distribution of skilled cardiac surgeons across different regions can limit the availability of CABG procedures. In areas where there is a shortage of qualified surgeons, patients may face long waiting lists and delays in receiving treatment. This disparity in access can adversely affect patient care and slow down the adoption of CABG devices in underserved regions.

Category-Wise Acumens

How the Minimally Invasive Nature Surge the Growth of Minimally Invasive CABG Devices Segment?

Minimally invasive CABG devices segment shows significant growth in the coronary artery bypass graft devices market. The growing popularity of off-pump coronary artery bypass grafting (CABG) is largely attributed to its minimally invasive nature, which appeals to both patients and surgeons. This approach, performed without the use of a heart-lung machine or cardiopulmonary bypass device, allows the heart to continue functioning normally during the procedure. As a result, patients experience shorter hospital stays and faster recoveries compared to traditional CABG methods. The significant benefits of off-pump CABG, including reduced post-operative complications and a lower risk of bleeding, stroke, and cardiac muscle injury, make it an attractive option for both patients and healthcare providers.

Manufacturers in the CABG devices market can leverage the growing demand for off-pump technology by investing in research and development to enhance their product offerings. The off-pump CABG segment is projected to grow at the fastest rate during the forecast period, driven by continuous innovations and advancements in this technology. These innovations focus on improving safety, efficiency, and overall patient outcomes, thereby expanding the adoption of off-pump procedures in various cardiac treatments.

As the industry moves towards greater adoption of off-pump CABG, manufacturers have a prime opportunity to capitalize on this trend. By expanding their product portfolios and investing in new technologies, they can meet the rising demand for off-pump solutions and strengthen their market position. This segment's growth reflects the broader trend towards minimally invasive surgical techniques, which aim to enhance patient care and surgical outcomes while minimizing recovery times.

How do the Advancements in Cardiovascular Surgery Foster the Growth of the Off-Pump CABG Devices Segment?

Off-pump CABG devices segment shows significant growth in the coronary artery bypass graft devices market. Off-pump coronary artery bypass grafting (CABG) represents a significant advancement in cardiovascular surgery, distinguished by its approach of performing the procedure without the use of a heart-lung machine or cardiopulmonary bypass device. This technique allows the heart to continue its normal function of supplying blood to the body during the surgery, which is a major shift from traditional methods that temporarily halt heart function.

The appeal of off-pump CABG lies in its minimally invasive nature, which offers several advantages. The procedure's reduced invasiveness leads to fewer complications, such as bleeding and stroke, and minimizes the risk of injury to the cardiac muscle. These benefits contribute to enhanced safety and efficiency, making it an attractive option for both patients and surgeons. Additionally, the reduced need for a heart-lung machine means that patients often experience shorter hospital stays and quicker recoveries compared to traditional CABG methods. This rapid recovery is a key factor driving the adoption of off-pump CABG. Manufacturers in the cardiovascular field are increasingly recognizing the potential of off-pump CABG technology. They are investing heavily in research and development to refine this approach and expand their product portfolios. The ongoing innovations by industry players further support the technology's integration into various cardiac procedures, thus propelling the segment's growth. The combination of advanced technology, reduced post-operative complications, and accelerated patient recovery positions off-pump CABG as a leading choice in the evolving landscape of coronary artery bypass surgery.Top of Form

How the Advanced Cardiac Care Infrastructure and Specialized Personnel Surge the Growth of Hospitals Segment?

The hospital segment shows significant growth in the Coronary Artery Bypass Graft Devices Market. Hospitals play a crucial role in the growth of the coronary artery bypass graft (CABG) devices market by investing in advanced cardiac care infrastructure and specialized personnel. Many hospitals are enhancing their cardiac capabilities by equipping their facilities with state-of-the-art cardiac catheterization labs, operating rooms, and intensive care units (ICUs). These upgrades include advanced monitoring and imaging technologies that support precise and effective CABG procedures.

Moreover, hospitals with dedicated cardiac surgery programs benefit from having highly skilled cardiac surgeons, anesthesiologists, and support staff who specialize in performing CABG surgeries. This specialized expertise ensures high-quality care and improves surgical outcomes. Comprehensive postoperative care is also a significant factor, with hospitals providing detailed monitoring in the ICU, effective pain management, and diligent complication management. In addition, cardiac rehabilitation services are offered to help patients recover physically and adjust their lifestyles post-surgery.

The growth in the CABG devices market is further driven by the increasing number of new heart-related cases, which boosts demand for advanced surgical interventions. Additionally, patient preference for healthcare facilities with cutting-edge infrastructure and highly experienced medical professionals contributes to this market expansion. As hospitals continue to enhance their cardiac care capabilities and attract patients seeking the best possible outcomes, the demand for CABG devices and related services is expected to rise accordingly.

Country/Region-wise Acumens

How does the Increasing Prevalence of Cardiovascular Conditions Surge the Growth of the Coronary Artery Bypass Graft Devices Market in North America?

North America is estimated to hold a significant share in the coronary artery bypass graft (CABG) devices market and is poised to maintain its dominant position throughout the forecast period driven by the increase in the global prevalence of cardiovascular conditions, such as coronary artery disease (CAD), strokes, and atrial fibrillation, driven by a rise in lifestyle-related diseases like diabetes and obesity. These health trends are leading to a greater need for CABG procedures, which in turn fuels the demand for surgical grafts and related devices.

The region is also at the forefront of innovation in cardiovascular medicine. Ongoing research efforts are focused on developing new surgical techniques, improving perioperative care, and introducing cutting-edge technologies aimed at optimizing outcomes for CABG surgeries. This commitment to advancement underscores North America's leadership in the field.

Additionally, North America's advanced healthcare infrastructure plays a critical role in sustaining market growth. The region is home to state-of-the-art hospitals and specialized cardiac centers equipped with the latest medical technologies. This high level of infrastructure supports the delivery of exceptional cardiac care and facilitates the effective implementation of advanced CABG procedures. The combination of rising cardiovascular disease prevalence, innovation in medical techniques, and robust healthcare facilities positions North America as a key player in the global CABG devices market.

How the High-Quality Healthcare Infrastructure and Sophisticated Cardiac Interventions Enable the Growth of Coronary Artery Bypass Graft Devices Market in Asia Pacific?

Asia Pacific is anticipated to witness the fastest growth in the coronary artery bypass graft devices market during the forecast period. The rise in disposable income, which allows patients to afford advanced cardiac treatments, including CABG procedures. As more individuals have the financial means to access high-quality healthcare, the demand for sophisticated cardiac interventions continues to grow. Government initiatives also play a crucial role in market expansion. Many governments are investing in healthcare development and promoting cardiovascular health through various programs and policies. These initiatives support the advancement of cardiac care and encourage the adoption of CABG procedures.

Increasing awareness about heart diseases and the importance of early treatment has led to more proactive approaches in diagnosing and managing cardiovascular conditions. This heightened awareness is contributing to early diagnosis and intervention, which drives demand for CABG surgeries and related devices. Medical tourism is another emerging trend contributing to market growth. Some countries have become popular destinations for CABG procedures due to their advanced healthcare facilities and competitive pricing. This trend attracts patients from around the world, further boosting demand for CABG devices.

Additionally, there is a growing adoption of minimally invasive CABG procedures, which offer benefits such as shorter recovery times and reduced post-operative complications. The focus on cost-effective treatment options is also increasing, as both patients and healthcare systems seek to balance quality care with financial considerations. Also, the continuous development of innovative CABG devices is enhancing the effectiveness and safety of these procedures. Advances in technology are leading to the creation of new devices that improve surgical outcomes and patient experiences, driving further growth in the market.

Competitive Landscape

The coronary artery bypass graft (CABG) devices market is characterized by a mix of established medical device companies and specialized players. While the overall market is relatively concentrated, there is ongoing competition based on factors such as product innovation, technological advancements, and geographical reach.

The organizations focus on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the Coronary Artery Bypass Graft Devices Market include:

Terumo Cardiovascular Systems Corporation, Edwards Lifesciences Corporation, Boston Scientific Corporation, Medtronic, Abbott, Teleflex Incorporated, AtriCure, Inc.

Latest Developments:

In August 2022, Medtronic plc announced the acquisition of Affera, Inc. This acquisition increased the company's cardiac ablation portfolio by adding its first cardiac mapping and navigation platform. The platform includes a novel, completely integrated diagnostic, focal pulsed field, and radiofrequency ablation solution.

In August 2022, the Grand Pharmaceutical Group of China invested EUR 15 million in Xeltis, a well-known medical device company with clinical-stage headquarters in the Netherlands. Grand Pharmaceutical has developed a polymer-based cardiovascular therapy device. CABG surgery uses heart valves and blood arteries with tiny diameters as restoration devices.

In January 2022, Humacyte, Inc. released data from the first preclinical investigation of the use of Humacyte's small-diameter (3.5mm) Human Acellular Vessel (HAV) in CABG at Advanced Therapies Week.

Coronary Artery Bypass Graft Devices Market, By Category

• Product Type:
• On-Pump CABG Devices
• Off-Pump CABG Devices
• Minimally Invasive CABG Devices
• End-User:
• Hospitals
• Cardiac Surgery Centers
• Ambulatory Surgical Centers
• Region:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Coronary Artery Bypass Graft Devices Market, By Product Type

• On-pump CABG devices
• Off-pump CABG devices
• Minimally invasive CABG devices

5. Coronary Artery Bypass Graft Devices Market, By End-User

• Hospitals
• Cardiac surgery centers
• Ambulatory surgical centers

6. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

7. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

8. Competitive Landscape

• Key Players
• Market Share Analysis

9. Company Profiles

• Terumo Cardiovascular Systems Corporation
• Edwards Lifesciences Corporation
• Boston Scientific Corporation
• Medtronic
• Abbott
• Teleflex Incorporated
• AtriCure, Inc.

10. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

11. Appendix

• List of Abbreviations
• Sources and References